|
Welcome to the Physical Pharmacy & Biopharmaceutics Section |
 |
Physical Pharmacy and Biopharmaceutics
The Physical Pharmacy and Biopharmaceutics (PPB) Section is composed of AAPS members
whose scientific interests are in the physicochemical and biological factors that
impact the design and delivery of small molecules and biologics. PPB is a multidisciplinary
section that focuses on preformulation, biopharmaceutics, drug absorption, nanotechnology,
and drug delivery systems design and performance including targeted drug delivery.
PPB provides an interactive forum for the exchange of information pertaining to
the selection of developable drug candidates at the drug discovery-development interface,
characterization of drug substance and excipients, studies of relationships between
drugs' physicochemical and biopharmaceutical properties and physiological considerations
at the cellular, organ, and whole animal levels, and overcoming drug absorption
and delivery barriers via drug delivery technologies.
FIP Pharmaceutical Sciences World Congress 2010 in association with the AAPS Annual Meeting & Exposition
PPB Programming
Program-at-a-Glance
Meeting Website
Meeting Registration
Registration rates increase after September 10, 2010.
Housing Reservations
Hotel Reservation Deadline: October 22, 2010
Volunteer for the PPB Section Booth (Coming Soon)
|
 |
 |
 |
 |
|
Please check back frequently for more information about the brand new PPB Section!
|
|
|
Chair Michael J. Hageman, Ph.D. Bristol-Myers Squibb Princeton, NJ United States
| Chair-Elect Dr. Duxin Sun, Ph.D. University of Michigan Ann Arbor, MI UNITED STATES
| Vice Chair Sherry Ku, Ph.D. TWI Anchen Pharmaceutical Taipei, Taiwan, Province of China
| Secretary/Treasurer Tycho H. Heimbach, Ph.D. Novartis Pharmaceuticals Corporation East Hanover, NJ UNITED STATES
| Past Chair Dr. Lawrence X. Yu, Ph.D. Food and Drug Administration North Potomac, MD United States
| Member at Large Dr. Marilyn E. Morris, Ph.D. University at Buffalo, SUNY Amherst, NY United States
| Annual Meeting Program Committee Dr. Duxin Sun, Ph.D. University of Michigan Ann Arbor, MI UNITED STATES
| Annual Meeting Screeners Committee Allen C. Templeton, Ph.D Merck and Co., Inc. West Point, PA United States
| Annual Meeting Screeners Committee Dr. Nathalie Y. Toussaint, Ph.D. Bristol-Myers Squibb Princeton, NJ United States
| Content Advisory Committee Ping Tong Abbott Labs Abbott Park, IL United States
| Fellows Committee Gregory E. Amidon, Ph.D. University of Michigan Ann Arbor, MI United States
| Membership Strategic Oversight Committee Phenil J. Patel, Ph.D. Eli Lilly and Co. Indianapolis, IN
| National Biotech Conf Program Committee Dr. Giovanni M. Pauletti, Ph.D. University of Cincinnati Cincinnati, OH United States
| National Biotechnology Conference Screeners Committee Lori S. Burton, Ph.D Bristol-Myers Squibb, Inc. New Brunswick, NJ United States
| Nominations Committee Michael J. Hageman, Ph.D. Bristol-Myers Squibb Princeton, NJ United States
| Program Coordination Committee Dr. Duxin Sun, Ph.D. University of Michigan Ann Arbor, MI UNITED STATES
| Awards Committee Dr. Lillian Zhang, Ph.D CDER, FDA Silver Spring, MD United States
| Communications Committee Olafur S. Gudmundsson, Ph.D. Bristol-Myers Squibb Company Princeton, NJ UNITED STATES
| Communications Committee Balvinder S. Vig, Ph.D Bristol Myers Squibb New Brunswick, NJ UNITED STATES
| Webinar Committee Ping Gao, Ph.D. Abbott Highland Park, IL United States
| Webmasters Committee Weiyi Li Allergan Irvine, CA
| Staff Liaison Jake P. Harris AAPS Arlington, VA United States
| Staff Liaison Maria Nadeau AAPS Arlington, VA United States
|
|